Pharmacovigilance Briefs

April 2022 in “ Médecine ”

Michel Gerson

TLDR Covid-19 vaccination during pregnancy is safe for mothers and babies.

Two new studies supported the absence of obstetrical and neonatal risks associated with Covid-19 vaccination during pregnancy. The first study was a retrospective cohort study conducted in Ontario, including all births between December 14, 2020, and September 30, 2021. A total of 97,590 women received at least one dose of the vaccine, with 99.8% receiving mRNA vaccines.

View this study on shs.cairn.info →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Trial for TDM-105795 update from research office

in Research/Science 17 upvotes 2 years ago

The trial for TDM-105795 has been completed, and it was in phase 2A. The discussion seeks input on the next phases, 2B or 3, based on safety and efficacy.

community PP405 2a study was a safety study. Some rational explaining.

in Research/Science 22 upvotes 9 months ago

The conversation discusses the safety study of PP405, emphasizing that early trials focus on safety rather than efficacy, and that any efficacy data from such a short study should be viewed skeptically. It also highlights that the information released is primarily for securing funding, and that meaningful efficacy results are expected in later phases.

community Heads up for EU Fin users: Finasteride prescription has been toughened up in France

in Finasteride/Dutasteride 106 upvotes 1 month ago

Finasteride prescriptions in France now require an annual certificate acknowledging psychiatric and sexual risks, as the European Medicines Agency recognizes these risks. The conversation discusses the potential mental health effects of Finasteride, with some users reporting side effects and others questioning the statistical significance of these findings.

community European Medecine Agency (EMA) review of Finasteride and Dutasteride

in Finasteride/Dutasteride 37 upvotes 1 year ago

Concerns about a potential ban on finasteride and dutasteride due to side effects, with users advocating for continued access and informed choice. Alternative treatments like pyrilutamide are also mentioned.

community Pelage have presented only phase 2a. The rest of phase 2 for PP405 will be presented at a later medical meeting

in Chat 30 upvotes 2 months ago

PP405's phase 2a trial results were presented, focusing on safety and pharmacokinetics, with a future meeting planned to share the full dataset. The trial includes a randomized controlled portion and an open-label extension, with no indication of phase 2B completion.

community CMDh final position just arrived. Finasteride and Dutasteride to remain accessible in the EU

in Finasteride/Dutasteride 168 upvotes 11 months ago

Finasteride and Dutasteride will remain accessible in the EU despite objections from France and Belgium. Users discuss the ease of obtaining these medications in different countries and express relief and support for the EU's decision.

Similar Research

6 / 1000+ results

Novelty or Prudence? The Delicate Balance in Pharmacological Updates

research Reporting on Adverse Clinical Events

November 2015 in “Clin-Alert”

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

research Dipyridamole-Associated Shock and Pulmonary Edema; Oxcarbazepine-Induced Resistant Ventricular Fibrillation; Finasteride-Induced Pseudoporphyria; Suicidal Ideation Associated with Asenapine; Rediscovering Adverse Anticholinergic Effects; Prevalence of Adverse Drug Events in Ambulatory Care

1 citations , October 2011 in “Hospital Pharmacy”